Eduardo Collantes

Summary

Country: Spain

Publications

  1. pmc A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]
    Eduardo Collantes
    Hospital Reina Sofia, Cordoba, Spain
    BMC Fam Pract 3:10. 2002
  2. ncbi Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain
    Eduardo Collantes-Estevez
    Servicio de Reumatologia, Hospital Universitario Reina Sofia, Cordoba, Spain
    Curr Med Res Opin 19:402-10. 2003
  3. ncbi Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre study
    E Collantes-Estevez
    Department of Rheumatology, Reina Sofia University Hospital of Córdoba, Cordoba
    Rheumatology (Oxford) 44:1555-8. 2005
  4. pmc Usefulness of a centralized system of data collection for the development of an international multicentre registry of spondyloarthritis
    Ruxandra Schiotis
    Rheumatology Department, Hospital Universitario Reina Sofia, Avda Menendez Pidal s n, 14004 Cordoba, Spain
    Rheumatology (Oxford) 50:132-6. 2011
  5. ncbi Phenotypic differences between familial versus sporadic ankylosing spondylitis: a cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER)
    Raquel Almodovar
    Department of Rheumatology, Hospital Universitario Fundacion Alcorcon, Madrid, Spain
    Clin Exp Rheumatol 29:822-7. 2011
  6. ncbi [Assessing the efficacy of non-arthroscopic joint lavage in patients with osteoarthritis of the knee]
    Gabriel Frías
    Servicio de Reumatologia, Hospital Universitario Reina Sofia, Cordoba, Espana
    Reumatol Clin 5:189-93. 2009
  7. ncbi Increased efficacy of infliximab associated with methotrexate in ankylosing spondylitis
    Veronica C Pérez-Guijo
    Department of Rheumatology, Reina Sofia University Hospital of Córdoba, Menendez Pidal, S N, 14004 Cordoba, Spain
    Joint Bone Spine 74:254-8. 2007
  8. ncbi Infliximab reduces myeloperoxidase concentration in chronic inflammatory joint diseases
    Montserrat Feijoo
    Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad de Cordoba, Cordoba, Spain
    Pharmacology 83:211-6. 2009
  9. doi Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis
    Nuria Montala
    Department of Rheumatology, Hospital Santa Maria, Lleida, c Alcalde Rovira Roure 44, Lleida, Spain
    J Rheumatol 38:893-7. 2011
  10. pmc First signs and symptoms of spondyloarthritis--data from an inception cohort with a disease course of two years or less (REGISPONSER-Early)
    Marena Rojas-Vargas
    Rheumatology Department, Hospital Universitario Reina Sofia, HU Reina Sofía, Cordoba, Spain
    Rheumatology (Oxford) 48:404-9. 2009

Collaborators

  • Nuria Montala
  • Loreto Carmona
  • J Gratacos
  • C Gonzalez
  • Manuel Fernandez
  • Eduardo Collantes-Estevez
  • Pilar Font
  • Raquel Almodovar
  • Elisa Muñoz-Gomariz
  • Xavier Juanola
  • Ruxandra Schiotis
  • Juan Mulero
  • Alejandro Escudero
  • Carlos Montilla
  • Estefania Moreno
  • Pedro Zarco
  • Gabriel Frías
  • Marena Rojas-Vargas
  • Montserrat Feijoo
  • Veronica C Pérez-Guijo
  • E Collantes-Estevez
  • Rafael Ariza Ariza
  • Pedro Zarco-Montejo
  • Rafael Ariza
  • Enrique Batlle Gualda
  • Teresa Clavaguera Poch
  • María Cruz Fernández-Espartero
  • Eduardo Cuende Quintana
  • Miguel A Caracuel
  • Manuel Fernandez Prada
  • Inmaculada Tasset
  • Veronica Perez-Guijo
  • Pilar Fernández Dapica
  • Antonio Juan Mas
  • Isaac Tunez
  • Pedro Montilla
  • Virginia Villaverde
  • Adela Ruiz
  • Juan Carlos Torre Alonso
  • María C Castro
  • Maria Elia Brito
  • Ana Rita Cravo
  • Maria del Carmen Castro
  • R Sanmarti
  • P Zarco
  • M C Muñoz-Villanueva
  • J D Canete
  • J C Torre-Alonso
  • Cristina Fernandez-Perez

Detail Information

Publications10

  1. pmc A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]
    Eduardo Collantes
    Hospital Reina Sofia, Cordoba, Spain
    BMC Fam Pract 3:10. 2002
    ..Etoricoxib is a highly selective COX-2 inhibitor which was evaluated for the treatment of rheumatoid arthritis (RA)...
  2. ncbi Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain
    Eduardo Collantes-Estevez
    Servicio de Reumatologia, Hospital Universitario Reina Sofia, Cordoba, Spain
    Curr Med Res Opin 19:402-10. 2003
    ..2%). At baseline, most patients (77%) were being prescribed celecoxib 200 mg/day; during the study most (92.5%) received rofecoxib 25 mg/day. The mean interval between switch to rofecoxib and follow-up interview was 33 days...
  3. ncbi Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre study
    E Collantes-Estevez
    Department of Rheumatology, Reina Sofia University Hospital of Córdoba, Cordoba
    Rheumatology (Oxford) 44:1555-8. 2005
    ..To evaluate the therapeutic effectiveness of reducing the infliximab dose interval to 6 weeks in spondyloarthropathy patients not responding to 5 mg/kg every 8 weeks...
  4. pmc Usefulness of a centralized system of data collection for the development of an international multicentre registry of spondyloarthritis
    Ruxandra Schiotis
    Rheumatology Department, Hospital Universitario Reina Sofia, Avda Menendez Pidal s n, 14004 Cordoba, Spain
    Rheumatology (Oxford) 50:132-6. 2011
    ..To present the usefulness of a centralized system of data collection for the development of an international multicentre registry of SpA...
  5. ncbi Phenotypic differences between familial versus sporadic ankylosing spondylitis: a cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER)
    Raquel Almodovar
    Department of Rheumatology, Hospital Universitario Fundacion Alcorcon, Madrid, Spain
    Clin Exp Rheumatol 29:822-7. 2011
    ..To analyse potential differences in disease phenotype between patients with familial ankylosing spondylitis (AS) and sporadic AS...
  6. ncbi [Assessing the efficacy of non-arthroscopic joint lavage in patients with osteoarthritis of the knee]
    Gabriel Frías
    Servicio de Reumatologia, Hospital Universitario Reina Sofia, Cordoba, Espana
    Reumatol Clin 5:189-93. 2009
    ..To evaluate the efficacy of joint lavage in patients with osteoarthritis of the knee...
  7. ncbi Increased efficacy of infliximab associated with methotrexate in ankylosing spondylitis
    Veronica C Pérez-Guijo
    Department of Rheumatology, Reina Sofia University Hospital of Córdoba, Menendez Pidal, S N, 14004 Cordoba, Spain
    Joint Bone Spine 74:254-8. 2007
    ..The aims of this study were to assess the efficacy of infliximab (IFX) combined with methotrexate (MTX) versus IFX alone in the treatment of ankylosing spondylitis (AS)...
  8. ncbi Infliximab reduces myeloperoxidase concentration in chronic inflammatory joint diseases
    Montserrat Feijoo
    Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad de Cordoba, Cordoba, Spain
    Pharmacology 83:211-6. 2009
    ..Patients with active disease showed increases in concentrations of MPO and biomarkers of oxidation, but decreases in antioxidant parameters. After infliximab treatment, both inflammatory parameters and MPO concentrations were normalized...
  9. doi Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis
    Nuria Montala
    Department of Rheumatology, Hospital Santa Maria, Lleida, c Alcalde Rovira Roure 44, Lleida, Spain
    J Rheumatol 38:893-7. 2011
    ..Our objective was to estimate the prevalence of vertebral fractures in a representative Spanish population of patients with AS using a validated semiquantitative method, MorphoXpress(®)...
  10. pmc First signs and symptoms of spondyloarthritis--data from an inception cohort with a disease course of two years or less (REGISPONSER-Early)
    Marena Rojas-Vargas
    Rheumatology Department, Hospital Universitario Reina Sofia, HU Reina Sofía, Cordoba, Spain
    Rheumatology (Oxford) 48:404-9. 2009
    ..To determine the first signs and symptoms, and the clinical, biological and radiological characteristics of patients with early SpA...